Comparative Pharmacology
Head-to-head clinical analysis: HALCION versus LIBERVANT.
Peer-Reviewed Evidence
Head-to-head clinical analysis: HALCION versus LIBERVANT.
HALCION vs LIBERVANT
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Triazolam is a benzodiazepine that enhances the effect of GABA at the GABA-A receptor, increasing chloride ion conductance and causing neuronal hyperpolarization, leading to CNS depression.
GABA-A receptor positive allosteric modulator; enhances inhibitory neurotransmission.
0.25 mg orally once daily at bedtime, maximum 0.5 mg per day.
0.25 mg intravenously over 2 minutes, may repeat once after 15 minutes if inadequate response; maximum total dose 0.5 mg.
None Documented
None Documented
Terminal elimination half-life is 1.5–5.5 hours (mean 2.5 hours). Short half-life minimizes next-day sedation.
Terminal elimination half-life is approximately 2–4 hours in patients with normal renal function; may be prolonged up to 8–12 hours in severe renal impairment (CrCl <30 mL/min).
Primarily renal (80%) as conjugated metabolites; fecal (8%); unchanged drug <1%.
Primarily renal excretion of unchanged drug (approximately 85%) and glucuronide conjugates (approximately 10%); biliary/fecal excretion accounts for less than 5%.
Category C
Category C
Benzodiazepine
Benzodiazepine